GlaxoSmithKline (GSK) has plans to open an approximately $549m (£400m) biotechnology campus in Stevenage, UK, which would possibly create up to 5,000 skilled jobs in the coming five to ten years.
The plan for the new hub was developed in collaboration with Stevenage Bioscience Catalyst (SBC), the UK Government, Stevenage Borough Council and the Local Enterprise Partnership.
Image: GSK’s R&D site in Stevenage, UK. Credit: GSK / Flickr.
{iframe}https://www.pharmaceutical-technology.com/news/gsk-biotech-hub-stevenage/{/iframe}